StartsideATBPF • OTCMKTS
add
Antibe Therapeutics Ord Shs
Forrige sluttkurs
0,22 $
Årsintervall
0,11 $ - 0,89 $
Gjennomsnittlig volum
27,54k
P/E-tall
-
Utbytte
-
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
| (CAD) | des. 2023info | Endring år til år |
|---|---|---|
Omsetning | — | — |
Driftskostnader | 4,60 mill. | −1,42 % |
Nettoomsetning | −4,21 mill. | 2,39 % |
Netto resultatmargin | — | — |
Fortjeneste per aksje | −0,08 | 0,50 % |
EBITDA | — | — |
Faktisk avgiftssats | — | — |
Balanseregnskap
Totale aktiva
Totale passiva
| (CAD) | des. 2023info | Endring år til år |
|---|---|---|
Kontant / kortsiktige inv. | 24,91 mill. | −41,20 % |
Totale aktiva | 56,36 mill. | −23,56 % |
Totale passiva | 30,42 mill. | −0,13 % |
Total egenkapital | 25,94 mill. | — |
Utestående aksjer | 52,67 mill. | — |
P/B-forhold | 0,44 | — |
Avkastning på aktiva | −19,71 % | — |
Avkastning på kapital | −41,30 % | — |
Kontantstrøm
Netto kontantstrøm
| (CAD) | des. 2023info | Endring år til år |
|---|---|---|
Nettoomsetning | −4,21 mill. | 2,39 % |
Kontantstrøm fra drift | −3,84 mill. | −6,66 % |
Kontanter fra investering | 11,04 mill. | 1 975,38 % |
Kontanter fra finansiering | — | — |
Netto kontantstrøm | 7,20 mill. | 334,09 % |
Fri kontantstrøm | −2,47 mill. | −2 419,13 % |
Om
Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.
On June 1, 2020, the company announced positive results in the final Phase 2 trial of its first drug Otenaproxesul.
On March 29, 2021, the drug's Investigational New Drug application was cleared by the US Food and Drug Administration, allowing for human trials.
In May 2024 the company went bankrupt and its stock was delisted from the Toronto Stock Exchange. Wikipedia
Grunnlagt
2009
Nettsted
Ansatte
11
